Suppr超能文献

静脉输液工作流程管理技术实施前后的肠外产品错误检测

Parenteral product error detection before and after implementation of intravenous workflow management technology.

作者信息

Wright Kelly R, Dekarske Brian, Clark John S, Chaffee Bruce W

机构信息

1 Department of Pharmacy Services, Michigan Medicine, Ann Arbor, USA.

2 Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, USA.

出版信息

J Oncol Pharm Pract. 2019 Jan;25(1):5-15. doi: 10.1177/1078155217723695. Epub 2017 Aug 4.

Abstract

OBJECTIVE

To assess the difference in pharmacy error detection rates when using a manual process compared to an intravenous workflow management system for the preparation of parenteral medications.

METHODS

Baseline error data were collected by staff using a standard form over a four-day time period before intravenous workflow management system implementation and compared to 48 weeks of electronically collected data following implementation. The chi-square test was used for statistical comparisons.

RESULTS

The ability to detect an error during the intravenous preparation process increased immediately following implementation, but this difference was not sustained and was not statistically different when the entire post-implementation time period was compared to the baseline sample. The most prevalent errors at baseline were wrong drug amount (36.4%) and wrong base solution (22.7%). Post-implementation product expiration (26.1%), wrong diluent or base (17.9%), and wrong drug amount (19.2%) were the most prevalent errors. Barcode scanning technology detected 60% of the errors during the post-implementation period. A decrease in error detection over time was observed post-implementation and was attributed to corrections and additions to the intravenous workflow management library and better prospective identification of potential errors by staff as they adjusted to the system. The use of serial imaging enabled pharmacists to detect errors prospectively, which may have previously been undetected using the traditional intravenous preparation process.

CONCLUSION

The implementation of intravenous workflow management technology was unable to detect a statistically significant greater percentage of sterile product preparation errors compared with the baseline time period. Statistical significance was achieved during three of the first four months following implementation ( P < 0.05); however, this statistically significant increase was not maintained when the entire post-implementation sample was included.

摘要

目的

评估在制备肠胃外用药时,使用人工流程与静脉内工作流程管理系统相比,药房差错检测率的差异。

方法

在实施静脉内工作流程管理系统之前的四天时间里,工作人员使用标准表格收集基线差错数据,并将其与实施后48周通过电子方式收集的数据进行比较。采用卡方检验进行统计比较。

结果

在实施静脉内制剂制备流程后,检测差错的能力立即提高,但这种差异未持续存在,且将整个实施后的时间段与基线样本进行比较时,差异无统计学意义。基线时最常见的差错是药物剂量错误(36.4%)和基础溶液错误(22.7%)。实施后最常见的差错是产品过期(26.1%)、稀释剂或基础错误(17.9%)以及药物剂量错误(19.2%)。条形码扫描技术在实施后阶段检测出60%的差错。实施后观察到差错检测率随时间下降,这归因于对静脉内工作流程管理库的修正和补充,以及工作人员在适应系统过程中对潜在差错的更好的前瞻性识别。串行成像的使用使药剂师能够前瞻性地检测差错,而这些差错在以前使用传统静脉内制剂制备流程时可能未被发现。

结论

与基线时间段相比,静脉内工作流程管理技术的实施未能检测出无菌产品制备差错的统计学上显著更高的百分比。在实施后的前四个月中有三个月达到了统计学显著性(P < 0.05);然而,当纳入整个实施后的样本时,这种统计学上的显著增加并未保持。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验